Fundraising Fox
Tactogen
7 known investors
Find your way into Tactogen
Sign up to see every warm intro you have to Tactogen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tactogen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds. The company operates in the neuroscience and pharmaceutical drug development space.
Founders & leadership
MB
Matthew BaggottCEOMatthew Baggott holds a PhD in neuroscience and has spent three decades in roles involving data science, preclinical pharmacology, clinical research, genomics, and drug development. He is CEO of Tactogen, which develops novel chemical compounds and conducts preclinical research in neuroscience and pharmaceutical development.
Investors · 7
__Twitter.png)
PsyMed Ventureslisted by PsyMed VenturesBerkeley
How we know: PsyMed Ventures's portfolio page · Not right? Tell us
10X CapitalreportedNew York
How we know: funding news · Not right? Tell us
Palo Santo VCreported
How we know: funding news · Not right? Tell us
WefunderreportedSan Francisco
How we know: press coverage · Not right? Tell us
In the news
Frequently asked questions
- What does Tactogen do?
- Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds. The company operates in the neuroscience and pharmaceutical drug development space.
- Who founded Tactogen?
- Tactogen was founded by Matthew Baggott.
- Who are Tactogen's investors?
- Tactogen's investors include Gaingels, Leafy Tunnel, Noetic, PsyMed Ventures, 10X Capital, Palo Santo VC, Wefunder.